OneSpan Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? OneSpan Inc trades at $18.22 (market cap $662.97M), while Roivant Sciences Ltd. Common Shares trades at $34.34 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 37.3× OneSpan Inc's market cap, and OneSpan Inc pays a 2.89% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold OneSpan Inc for 18 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| OSPN | ROIV | |
|---|---|---|
Market Cap | $662.97M | $24.72B |
Volume | 616,882 | 6,279,442 |
Sector | Technology | Health |
52-Week High | $18.42 | $41.81 |
52-Week Low | $10.15 | $16.04 |
Typical Hold Time | 18 Days | 0 Days |
Enterprise Value | $632.05M | $20.99B |
Dividend Yield | 2.89% | — |
Signals from Pluang's Aura AI — not financial advice
OneSpan (OSPN) trades at $17.70, down 3.7% in the last session, but maintains strong fundamentals with consistent earnings beats and robust profitability. The stock shows a bullish technical signal with support at $17 and resistance at $18. Recent Q2 2026 results exceeded expectations with EPS of $0.30 versus $0.231 expected, while the company introduced new authentication technology to drive future growth.
The outlook remains positive given strong analyst support (66.7% buy ratings) and solid financial metrics, though investors should monitor declining cash flow trends and competitive pressures in the cybersecurity sector. The stock presents value opportunity with P/E of 10.16 and ROE of 26.51%, but faces execution risks in maintaining subscription revenue growth.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →